Chlamydiae host cell interactions revealed using DNA microarrays

James B Mahony1

  • 1Department of Pathology and Molecular Medicine, McMaster University, Regional Virology and Chlamydiology Laboratory, St. Joseph's Healthcare, Hamilton, Ontario, Canada L8N 4A6. mahonyj@mcmaster.ca

Insights

Chlamydia pneumoniae infection activates host cell signaling pathways MEK/ERK and PI 3-kinase/Akt, crucial for bacterial invasion. Chlamydial gene expression is temporally regulated, revealing potential virulence factors like CpnPK1 for antimicrobial development.

Area of Science:

  • Microbiology
  • Cell Biology
  • Infectious Diseases

Background:

  • Chlamydiae are obligate intracellular bacteria residing within a host cell vacuole.
  • Understanding pathogen-host interactions is key to developing new antimicrobials.

Purpose of the Study:

  • To investigate host-pathogen interactions during Chlamydia pneumoniae infection.
  • To identify key host cell signaling pathways and bacterial factors involved in infection.

Main Methods:

  • cDNA microarrays and reverse transcriptase PCR were used to analyze gene expression.
  • Pharmacological inhibitors and GTPase assays assessed the role of signaling pathways and Rho GTPases in invasion.
  • HEp2 cells were used as a model eukaryotic system.

Main Results:

  • MEK/ERK and PI 3-kinase/Akt pathways were rapidly activated upon infection.
  • Inhibition of these pathways and Rho GTPase activity blocked bacterial invasion.
  • Host cell genes for cytokines and growth factors were upregulated early post-infection.
  • Chlamydial gene expression showed temporal regulation, with novel Ser/Thr kinases and a phosphatase identified.

Conclusions:

  • Host cell signaling pathways are essential for Chlamydia pneumoniae invasion.
  • Temporal regulation of chlamydial gene expression suggests a complex replication cycle.
  • The identified chlamydial protein kinase CpnPK1 is a potential type III effector and virulence factor.
  • Further understanding of these interactions can lead to novel antimicrobial targets.